Literature DB >> 28586374

Nocturnal leg cramps: Prevalence and associations with demographics, sleep disturbance symptoms, medical conditions, and cardiometabolic risk factors.

Michael A Grandner1, John W Winkelman2,3.   

Abstract

BACKGROUND: Nocturnal leg cramps (NLC) are common and poorly understood.
OBJECTIVE: To determine the prevalence of NLC and associations with cardiometabolic, sleep, and behavioral risk factors in the US population.
DESIGN: Cross-sectional epidemiology. PARTICIPANTS: National Health and Nutrition Examination Survey, 2005-2006 and 2007-2008 waves. MAIN OUTCOME(S) AND MEASURE(S): NLC were assessed with, "In the past month, how often did you have leg cramps while trying to sleep?" Responses were categorized as None, Mild, or Moderate-Severe. Demographics, medical history, sleep disturbances, and cardiometabolic risk factors were evaluated using the 2005-2006 dataset. Variables that demonstrated significant relationships to NLC after adjusting for age, sex, education, and BMI were assessed in the 2007-2008 dataset. Variables that were still significant were entered into a forward stepwise regression model combining both waves, to determine which variables best explained the variance in NLC.
RESULTS: Prevalence was 24-25% reporting mild and 6% reporting moderate-severe NLC. NLC increased with age, lower education, unemployment, shorter sleep duration, all assessed sleep symptoms (nocturnal "leg jerks", snoring, snorting/gasping, difficulty falling asleep, difficulty maintaining sleep, non-restorative sleep, sleepiness, use of sleep medications), higher BMI, smoking, medical history (hypertension, heart failure, angina, stroke, arthritis, respiratory disease, and cancer), depression symptoms, and biomarkers (CRP, HbA1c, calcium, cadmium, red blood cells). Stepwise analysis showed that moderate-severe nocturnal leg cramps were associated with (in decreasing order of partial R2): leg jerks, poor overall health, arthritis, difficulty falling asleep, age, nonrestorative sleep, red blood cell count, lower education, angina, and difficulty maintaining sleep. CONCLUSIONS AND RELEVANCE: Based on this first large, representative study, NLC occurring >5x per month are reported by 6% of the adult US population. Sleep disturbance symptoms and health conditions are associated with higher frequency of NLC, suggesting that NLC is a marker, and possibly contributor, to poor sleep and general health.

Entities:  

Mesh:

Year:  2017        PMID: 28586374      PMCID: PMC5460850          DOI: 10.1371/journal.pone.0178465

Source DB:  PubMed          Journal:  PLoS One        ISSN: 1932-6203            Impact factor:   3.240


Introduction

Nocturnal leg cramps (NLC) are common and their pathophysiology is poorly understood[1, 2]. Their primary morbidity is sleep disturbance and its next-day consequences[3]. Based on small primary care practice surveys[4-6], NLC may occur more commonly with increased age and in those with worse overall health[7]. Other associations with NLC include female sex, leg claudication, electrolyte imbalance, pregnancy, peripheral neuropathy, peripheral vascular disease, angina, and arthritis[8]. Potential medication etiologies include inhaled long-acting beta-agonists, statins, and diuretics[9]. Existing prevalence data suggest that 37–50% of older adults have such leg cramps[4, 5, 10]. In one study in an older population[4], 24% of patients with NLC reported that they were "very distressing". Nevertheless, they are often invisible to clinicians as a minority of patients report them in clinical encounters[5]. An improved understanding of the epidemiology of NLC is a first step in identifying clinically-appropriate methods for recognition and treatment. To estimate the population-level prevalence of NLC, as well as associations with a wide range of potential correlates, we examined data from the National Health and Nutrition Examination Survey (NHANES). The 2005–2006 NHANES wave was employed as a test sample and the 2007–2008 wave as a validation sample to determine correlates of NLC in a representative US population sample. Hypotheses of the study were that (1) prevalence of NLC increases with age and is more prevalent among women, (2) NLC are associated with other sleep symptoms, (3) NLC are more commonly experienced by individuals with a history of poor health and/or cardiovascular disease, and (4) the report of NLC will coincide with elevated physiologic health risk factors.

Methods

Data source

Participants included respondents to the 2005–2006 and 2007–2008 waves of the National Health and Nutrition Examination Survey (NHANES), conducted by the Centers for Disease Control and Prevention[11]. The NHANES data, methodology, and procedures have been previously reported (http://www.cdc.gov/nchs/nhanes). The NHANES is designed to ensure generalizability to the entire US population. Given the complexity of the survey design, coupled with variable probabilities of selection, the data used in the following analyses were also weighted to control for representativeness[11]. Presently, data on adults ages 18–80+ years with complete data were analyzed. All respondents provided informed consent.

Measures

Full details on measures are reported in freely-available NHANES manuals and on the NHANES website. Variables were chosen if they were present in both the 2005–2006 and 2007–2008 datasets, and have been shown to be associated previously with NLC or could plausibly be related to sleep difficulties associated with leg cramps.

Sleep symptoms

NLC were assessed with the item, “In the past month, how often did you have…” One item specified, “leg cramps when trying to sleep?” Responses were categorized as “None,” “Mild” (<15 nights/month), or “Moderate-Severe” (≥15 nights/month). Other sleep variables that were categorized this way included, “trouble falling asleep,” “wake up during the night and had trouble getting back to sleep,” “feel unrested during the day, no matter how many hours of sleep you had,” “feel excessively or overly sleepy during the day,” “take sleeping pills or other medication to help with sleep,” and “leg jerks while trying to sleep.” Snoring and snorting/gasping during sleep (symptoms of sleep-related breathing disorders) were coded as “Never,” “Rarely (1–2 nights per week),” “Occasionally (3–4 nights per week),” and “Frequently (≥5 nights per week).” Typical weekday sleep duration was recorded in whole numbers as a continuous variable.

Demographics and socioeconomics

Age was reported in years and categorized in 10-year groups. Sex was self-reported as male or female. Education level was reported as college graduate, some college, high school, or less than high school. Race/ethnicity was coded as non-Hispanic White, Black/African-American, Hispanic/Latino, or Asian/Other. Employment was categorized as yes or no, and typical weekly work hours were coded as a continuous variable. Marital status was reported as married, divorced/widowed/separated, never married, or living with partner.

Health history

Overall health was self-rated as excellent, very good, good, fair, or poor. History of hypertension, taking antihypertensive medication, diuretics or long-acting beta agonists, high cholesterol, diabetes, coronary heart disease, heart failure, angina, heart attack, stroke, arthritis, respiratory disease (bronchitis or emphysema), liver disease, thyroid disease, asthma, cancer, and current smoking were self-reported. Depression was evaluated with the Patient Health Questionnaire[12], including total scores computed with and without the sleep disturbance item.

Physiologic markers of health

Systolic and diastolic blood pressure were computed based on the average of three readings. Body Mass Index (BMI) was recorded as kg/m2. Blood draws were used to estimate levels of cholesterol, creatinine, calcium, potassium, chloride, sodium, folate, c-reactive protein (CRP), iron, ferritin, HbA1C%, glucose, insulin, parathyroid hormone, bicarbonate, vitamins B12, E, and B6, and counts of red and white blood cells. Urine analysis determined levels of cadmium, mercury, and lead.

Statistical analyses

Univariate comparisons for all variables across severity of nocturnal leg cramps were evaluated using ANOVA or X2 as appropriate. The primary analytic strategy was to use the 2005–2006 dataset as a test sample in order to determine which variables should be explored further. To be considered for inclusion in the validation sample (2007–2008), variables needed to demonstrate p<0.05 in the test sample (2005–2006) in a multinomial logistic regression model adjusted for age and sex, with NLC as outcome (either mild or moderate-severe, versus none All variables that passed this test were assessed in separate models (with mild or moderate-severe NLC outcomes) using 2007–2008 data. These models were (1) unadjusted, (2) adjusted for age and sex, (3) adjusted for age, sex, education and BMI, and (4) adjusted for age sex, BMI, employment, hypertension, diabetes, and depression. The final model may be useful for examining effects regarding general cardiometabolic morbidity, though it may be over-controlled and thus should be interpreted cautiously. Finally, since many predictors may explain similar variance, a forward stepwise regression model utilized the combined 2005–2006 and 2007–2008 datasets and included only variables that were significant in age and sex adjusted models in both of these waves, and were not collinear. This allowed for a wide screen of many potential predictors, refined that list in a second dataset, and further clarified which were the most important in the stepwise procedure. Two-tailed P-values of <0.05 were used. All calculations were performed using STATA/SE version 14 (STATA Corp, College Station TX).

Results

Sample characteristics

Weighted characteristics of the analytic samples are reported in Table 1, stratified by sampling wave (2005–2006 or 2007–2008). Prevalence of NLC was consistent across both waves, with approximately 30% reporting symptoms (in both cases, about 24% reported mild and about 6% reported moderate-severe symptoms). Because of the large number of variables originally explored, only those included in the final models are listed. The distributions of covariates are also shown by severity of NLC to explore bivariate relationships among variables using one-way ANOVA or chi-square.
Table 1

Characteristics of the sample, stratified by dataset and severity of nocturnal leg cramps.

VariableOverall SampleNocturnal Leg Cramps Severity
NoneMildModerate-Severep
2005–2006 Sample
%70.08%24.21%5.71%
Age≥804.18%3.21%6.04%7.35%<0.0001
70–797.29%5.96%9.66%13.64%
60–6910.71%10.00%12.67%11.20%
50–5917.07%14.18%23.62%25.02%
40–4920.58%21.52%18.48%18.05%
30–3918.36%20.80%13.05%11.12%
18–2921.81%24.33%16.48%13.63%
Sex% Female51.76%49.74%54.95%62.86%0.0001
Race/EthnicityNon-Hispanic White71.42%70.26%74.30%73.85%0.1187
Black/African-American11.72%12.24%10.81%9.04%
Hispanic/Latino11.44%12.06%9.78%10.68%
Asian/Other5.43%5.44%5.11%6.43%
EducationCollege Graduate26.02%27.92%23.59%13.64%0.0001
Some College31.35%31.39%31.34%31.15%
High School24.94%23.81%26.60%31.40%
Less Than High School17.70%16.87%18.46%23.81%
Marital StatusMarried55.43%55.20%56.70%53.43%<0.0001
Divorced, Widowed or Separated18.38%16.48%20.87%30.58%
Never Married18.15%20.30%14.11%8.75%
Living with partner8.04%8.02%8.32%7.24%
EmploymentUnemployed33.07%29.84%37.58%53.01%<0.0001
Body mass index (BMI)Continuous28.5 ± 6.728.2 ± 6.729.0 ± 6.629.5 ± 7.20.0014
SmokingCurrent Smoker24.03%24.26%21.71%31.31%0.0180
Overall HealthExcellent10.92%13.02%7.04%2.28%<0.0001
Very Good35.58%38.53%31.03%19.52%
Good37.36%35.30%42.01%42.05%
Fair13.95%11.94%16.88%25.64%
Poor2.20%1.20%3.04%10.51%
DepressionPHQ Score2.59 ± 3.582.19 ± 3.113.15 ± 3.855.06 ± 5.87<0.0001
PHQ Score (-Sleep)2.06 ± 3.071.74 ± 2.662.50 ± 3.314.11 ± 5.08
Sleep durationContinuous6.90 ± 1.396.97 ± 1.346.83 ± 1.406.41 ± 1.73<0.0001
SnoringFrequently32.35%30.17%35.57%45.32%<0.0001
Difficulty Falling AsleepModerate-Severe16.01%12.52%22.34%31.95%<0.0001
Difficulty Maintaining SleepModerate-Severe20.18%15.48%28.20%43.36%<0.0001
Non-Restorative SleepModerate-Severe26.34%22.92%31.45%46.43%<0.0001
Daytime SleepinessModerate-Severe18.43%15.48%22.91%35.85%<0.0001
Leg JerksModerate-Severe5.85%2.90%6.54%39.15%<0.0001
Sleep Medication UseFrequent8.84%6.96%11.60%20.25%<0.0001
2007–2008 Sample
%68.69%24.90%6.10%
Age≥804.34%3.74%5.01%8.09%<0.0001
70–797.10%6.13%9.10%9.66%
60–6911.36%9.63%14.95%16.15%
50–5917.65%15.59%21.95%23.26%
40–4919.75%20.28%19.08%16.57%
30–3917.78%19.79%13.82%11.44%
18–2922.02%24.84%16.09%14.84%
Sex% Female48.34%50.21%46.96%32.59%<0.0001
Race/EthnicityNon-Hispanic White69.22%68.59%70.62%70.67%0.6796
Black/African-American13.42%13.70%12.53%14.08%
Hispanic/Latino11.37%11.70%10.87%9.64%
Asian/Other5.99%6.00%5.98%5.61%
EducationCollege Graduate24.42%27.18%20.21%10.45%<0.0001
Some College20.80%19.28%21.37%36.12%
High School24.75%23.29%28.36%26.34%
Less Than High School30.02%30.25%30.06%27.09%
Marital StatusMarried56.51%55.94%59.66%49.81%<0.0001
Divorced, Widowed or Separated18.62%16.56%21.52%29.30%
Never Married17.97%20.14%13.68%11.62%
Living with partner6.91%7.36%5.14%9.27%
EmploymentUnemployed35.98%32.81%39.81%56.24%<0.0001
Body mass index (BMI)28.4 ± 6.628.0 ± 6.229.2 ± 7.330.1 ± 8.4<0.0001
SmokingCurrent Smoker23.46%22.44%23.76%33.81%0.0003
Overall HealthExcellent16.84%19.46%11.95%7.53%<0.0001
Very Good31.10%34.16%26.89%13.40%
Good33.72%33.15%36.66%27.58%
Fair14.65%11.12%18.78%38.08%
Poor3.69%2.11%5.72%13.41%
DepressionPHQ Score3.12 ± 4.052.64 ± 3.513.48 ± 4.287.03 ± 6.37<0.0001
PHQ Score (-Sleep)2.46 ± 3.482.06 ± 3.012.73 ± 3.695.66 ± 5.61
Sleep durationContinuous6.84 ± 1.396.92 ± 1.316.75 ± 1.436.22 ± 2.02<0.0001
SnoringFrequently31.70%29.25%35.47%44.46%<0.0001
Difficulty Falling AsleepModerate-Severe18.60%15.04%22.65%42.70%<0.0001
Difficulty Maintaining SleepModerate-Severe20.33%16.79%23.21%49.08%<0.0001
Non-Restorative SleepModerate-Severe27.68%23.30%32.50%57.82%<0.0001
Daytime SleepinessModerate-Severe18.39%15.36%20.24%45.93%<0.0001
Leg JerksModerate-Severe6.85%3.83%7.36%39.85%<0.0001
Sleep Medication UseFrequent8.90%6.97%10.10%26.03%<0.0001

2005–2006 dataset: Variable selection

Regarding the hierarchical regression strategy, all variables were examined using 2005–2006 data to determine inclusion in 2007–2008 models. Results are reported in Table 2. Variables with a significant relationship to NLC were then assessed using 2007–2008 data. The only variable that was retained despite not meeting criteria was race/ethnicity, which was felt to be important to include as a covariate due to its association with other health parameters.
Table 2

Relationships between nocturnal leg cramps and variables in the 2005–2006 wave, adjusted for age and sex.

MildModerate-SevereRetained for 2007–2008Included in Stepwise
VariableOR95% CIpOR95% CIp
EducationCollege Graduate1.00Reference1.00ReferenceYesYes
Some College1.23(0.98, 1.55)0.07282.12(1.28, 3.49)0.003
High School1.28(1.01, 1.62)0.04232.56(1.55, 4.25)0.0003
Less Than High School1.22(0.97, 1.54)0.09582.66(1.62, 4.39)0.0001
Marital StatusMarried1.00Reference1.00ReferenceYesYes
Divorced, Widowed, Separated0.98(0.79, 1.21)0.831.45(1.02, 2.07)0.04
Never Married1.00(0.79, 1.26)0.970.66(0.41, 1.05)0.08
Living with Partner1.34(0.98, 1.82)0.061.24(0.72, 2.15)0.44
Race/EthnicityNon-Hispanic White1.00Reference1.00ReferenceYes*No
Black/African-American0.91(0.76, 1.08)0.280.78(0.56, 1.10)0.16
Hispanic/Latino0.92(0.75, 1.13)0.451.10(0.74, 1.62)0.65
Asian/Other0.98(0.68, 1.42)0.921.29(0.68, 2.45)0.44
EmploymentYes1.02(0.85, 1.23)0.811.89(1.34, 2.67)0.00YesYes
Work HoursContinuous1.00(0.99, 1.01)0.851.00(0.99, 1.02)0.80NoNo
SmokingCurrent Smoker1.00(0.82, 1.22)0.991.82(1.32, 2.51)<0.0001YesYes
Sleep DurationContinuous0.91(0.86, 0.97)0.0010.73(0.65, 0.82)<0.0001YesYes
SnoringFrequent1.13(1.05, 1.21)0.0011.27(1.10, 1.45)0.001YesYes
Snorting/GaspingFrequent1.27(1.16, 1.40)<0.00011.52(1.31, 1.76)<0.0001YesYes
Difficulty Falling AsleepModerate-Severe1.65(1.47, 1.84)<0.00011.86(1.49, 2.33)<0.0001YesYes
Difficulty Maintaining SleepModerate-Severe1.75(1.57, 1.95)<0.00012.31(1.85, 2.89)<0.0001YesYes
Nonrestorative SleepModerate-Severe1.59(1.42, 1.77)<0.00012.30(1.84, 2.86)<0.0001YesYes
Daytime SleepinessModerate-Severe1.67(1.49, 1.87)<0.00012.22(1.77, 2.77)<0.0001YesYes
Sleep Medication UseModerate-Severe1.32(1.16, 1.50)<0.00011.66(1.37, 2.00)<0.0001YesYes
Leg JerksModerate-Severe2.99(2.56, 3.51)<0.00016.50(5.12, 8.25)<0.0001YesYes
Overall HealthExcellent1.00Reference1.00ReferenceYesYes
Very Good1.46(1.06, 2.02)0.022.78(1.11, 6.95)0.03
Good2.14(1.56, 2.92)<0.00016.48(2.66, 15.80)<0.0001
Fair2.40(1.69, 3.40)<0.000110.95(4.47, 26.82)<0.0001
Poor3.95(2.22, 7.05)<0.000139.68(14.43, 109.10)<0.0001
Antihypertensive MedsYes1.01(0.67, 1.52)0.970.82(0.41, 1.64)0.58NoNo
DiureticsYes1.00(0.77, 1.28)0.9731.57(1.08, 2.28)0.019YesYes
Long-acting beta agonistsYes10.21(1.22, 85.33)0.0323.42(0.28, 42.18)0.337YesNo
HypertensionYes1.12(0.93, 1.35)0.251.88(1.37, 2.59)0.0001YesYes
High CholesterolYes1.18(0.97, 1.44)0.101.26(0.90, 1.75)0.18NoNo
DiabetesYes1.44(1.10, 1.88)0.011.84(1.22, 2.78)0.004YesYes
Coronary Heart DiseaseYes1.17(0.80, 1.71)0.431.57(0.87, 2.84)0.13NoNo
Heart FailureYes1.65(1.09, 2.49)0.022.99(1.70, 5.26)0.0001YesYes
AnginaYes1.14(0.73, 1.76)0.572.01(1.16, 3.49)0.01YesYes
Heart AttackYes1.05(0.70, 1.57)0.812.38(1.39, 4.08)0.0001YesYes
StrokeYes1.14(0.75, 1.71)0.541.40(0.73, 2.71)0.31NoNo
ArthritisYes1.60(1.31, 1.95)<0.00012.72(1.91, 3.86)<0.0001YesYes
Respiratory DiseaseYes1.83(1.37, 2.45)<0.00012.23(1.47, 3.38)<0.0001YesYes
Liver DiseaseYes1.18(0.77, 1.81)0.441.61(0.85, 3.06)0.14NoNo
Thyroid DiseaseYes1.39(1.06, 1.82)0.021.29(0.86, 1.95)0.22YesYes
AsthmaYes1.61(1.21, 2.14)0.0071.83(1.18, 2.84)0.01YesYes
CancerYes1.13(0.85, 1.50)0.401.36(0.88, 2.10)0.17NoNo
DepressionScore1.09(1.06, 1.11)<0.00011.18(1.14, 1.22)<0.0001YesYes
Score without Sleep1.09(1.06, 1.12)<0.00011.20(1.15, 1.24)<0.0001YesYes
Systolic Blood PressuremmHg1.00(1.00, 1.01)0.351.00(0.99, 1.01)0.65NoNo
Diastolic Blood PressuremmHg1.00(0.99, 1.01)0.580.99(0.98, 1.01)0.34NoNo
Body Mass Indexkg/m21.01(1.00, 1.03)0.011.02(1.00, 1.04)0.02YesYes
Cholesterol (log)mg/dL1.43(0.97, 2.10)0.071.19(0.56, 2.54)0.65NoYes
Creatinine (log)mg/dL0.91(0.63, 1.33)0.631.20(0.64, 2.28)0.57NoNo
Calcium (log)mmol/L0.33(0.04, 2.85)0.320.00(0.00, 0.09)0.002YesYes
Potassium (log)mmol/L1.88(0.64, 5.55)0.254.30(0.68, 27.25)0.12NoNo
Chloride (log)mmol/L7.39(0.38, 145.42)0.190.22(0.00, 70.29)0.61NoNo
Sodium (log)mmol/L1.11(0.01, 144.31)0.970.00(0.00, 1.40)0.06NoNo
Folate (log)ng/ml0.84(0.71, 0.99)0.040.58(0.42, 0.79)0.001YesYes
C-Reactive Protein (log)mg/Dl1.09(1.02, 1.16)0.011.25(1.11, 1.40)0.0003YesYes
Iron (log)ug/dL0.89(0.73, 1.07)0.200.88(0.66, 1.17)0.38NoNo
Ferritin (log)ng/mL0.96(0.81, 1.15)0.661.01(0.98, 1.04)0.64NoNo
HbA1c%%1.23(1.12, 1.34)<0.00011.32(1.17, 1.50)<0.0001YesYes
Glucose (log)mg/Dl2.16(1.24, 3.75)0.013.22(1.18, 8.77)0.02YesYes
Insulin (log)uU/Ml1.10(0.94, 1.28)0.241.18(0.90, 1.54)0.24NoNo
Cadmium (log)ug/L1.02(0.89, 1.17)0.791.45(1.09, 1.92)0.01YesYes
Mercury (log)ug/L0.96(0.84, 1.09)0.510.93(0.73, 1.19)0.55NoNo
Lead (log)ug/L0.96(0.82, 1.13)0.651.02(0.72, 1.44)0.91NoNo
White Blood Cell CountThousand cells / uL1.01(0.98, 1.05)0.391.07(1.01, 1.13)0.03YesYes
Red Blood Cell CountMillion cells / uL0.99(0.82, 1.19)0.880.68(0.48, 0.96)0.03YesYes
Parathyroid (log)pg/mL0.99(0.82, 1.19)0.901.03(0.74, 1.45)0.84NoNo
Bicarbonatemmol/L0.97(0.93, 1.01)0.090.96(0.89, 1.03)0.25NoNo
Vitamin B12pg/mL1.00(1.00, 1.00)0.081.00(1.00, 1.00)0.10NoNo
Vitamin Eug/dL1.00(1.00, 1.00)0.731.00(1.00, 1.00)0.45NoNo
Vitamin B6nmol/L1.00(1.00, 1.00)0.181.00(1.00, 1.00)0.73NoNo

*Although not significant, Race/Ethnicity was retained because it was felt to be conceptually important for 2007–2008 analyses.

*Although not significant, Race/Ethnicity was retained because it was felt to be conceptually important for 2007–2008 analyses.

2007–2008 dataset: Adjusted models

Table 3 shows relationships between NLC and demographic and socioeconomic variables retained from the 2005–2006 dataset. In general, prevalence significantly increased with age, assessed continuously (3% increased likelihood per year) and categorically (Fig 1). Women were more likely to report symptoms in both samples. Race/ethnicity differences were seen in the fully-adjusted model, with Hispanics/Latinos reporting fewer leg cramps. Non-college graduates had a higher likelihood of NLC. In addition, unemployment was associated with increased likelihood of reporting NLC.
Table 3

Associations with moderate-severe nocturnal leg cramps in 2007–2008 (unadjusted and fully-adjusted models) *.

UnadjustedFully adjusted**
VariableOR95% CIPOR95% CIP
Demographics
AgeContinuous1.03(1.02, 1.03)<0.0001
Age≥801.00Reference
70–790.73(0.46, 1.15)0.172
60–690.77(0.50, 1.21)0.262
50–590.69(0.44, 1.08)0.103
40–490.38(0.24, 0.60)<0.0001
30–390.27(0.17, 0.42)<0.0001
18–290.28(0.17, 0.46)<0.0001
SexFemale2.09(1.61, 2.71)<0.0001
EducationCollege Graduate1.00Reference
Some College4.87(3.14, 7.57)<0.0001
High School2.94(1.83, 4.74)<0.0001
Less Than High School2.33(1.45, 3.76)0.0005
Race/EthnicityNon-Hispanic White1.00Reference
Black/African-American0.997(0.77, 1.29)0.9820.82(0.61, 1.12)0.211
Hispanic/Latino0.800(0.58, 1.10)0.1660.65(0.46, 0.91)0.013
Asian/Other0.906(0.52, 1.58)0.7301.17(0.66, 2.08)0.584
Marital StatusMarried1.00Reference
Divorced, Widowed, or Separated1.99(1.50, 2.63)<0.00011.37(1.01, 1.85)0.046
Never Married0.65(0.43, 0.99)0.0430.86(0.54, 1.38)0.540
Living With Partner1.42(0.87, 2.30)0.1631.63(0.97, 2.72)0.063
EmploymentUnemployed2.63(2.03, 3.42)<0.0001
Sleep
Sleep DurationContinuous0.71(0.6, 0.78)<0.00010.81(0.73, 0.89)<0.0001
SnoringNever1.00Reference1.00Reference
Rarely (1/week)1.01(0.63, 1.60)0.9831.17(0.70, 1.97)0.544
Occasionally (3-4/week)1.48(0.99, 2.21)0.0571.53(0.98, 2.40)0.063
Frequently (≥5/week)2.18(1.54, 3.08)<0.00011.75(1.17, 2.64)0.007
Snorting/ GaspingNever1.00Reference1.00Reference
Rarely (1/week)1.88(1.18, 2.99)0.0071.54(0.92, 2.59)0.100
Occasionally (3-4/week)2.59(1.70, 3.95)<0.00011.66(1.03, 2.69)0.038
Frequently (≥5/week)3.68(2.34, 5.78)<0.00011.89(1.07, 3.32)0.028
Difficulty Falling AsleepNone1.00Reference1.00Reference
Mild (<15/month)1.87(1.32, 2.66)0.00051.89(1.28, 2.80)0.001
Moderate-Severe5.98(4.21, 8.50)<0.00013.39(2.23, 5.14)<0.0001
Difficulty Maintaining SleepNone1.00Reference1.00Reference
Mild (<15/month)1.93(1.34, 2.76)0.00041.69(1.14, 2.50)0.009
Moderate-Severe6.98(4.89, 9.95)<0.00013.87(2.57, 5.81)<0.0001
Non-Restorative SleepNone1.00Reference1.00Reference
Mild (<15/month)1.71(1.16, 2.52)0.00682.32(1.51, 3.57)0.0001
Moderate-Severe6.36(4.43, 9.14)<0.00015.59(3.62, 8.63)<0.0001
Daytime SleepinessNone1.00Reference1.00Reference
Mild (<15/month)2.51(1.77, 3.56)<0.00012.94(2.02, 4.26)<0.0001
Moderate-Severe8.58(6.02, 12.23)<0.00016.06(4.01, 9.14)<0.0001
Use of Sleep MedicationNone1.00Reference1.00Reference
Mild (<15/month)1.92(1.31, 2.81)0.00081.56(1.01, 2.41)0.045
Moderate-Severe5.10(3.68, 7.06)<0.00012.71(1.79, 4.13)<0.0001
Leg JerksNone1.00Reference1.00Reference
Mild (<15/month)3.05(2.11, 4.43)<0.00012.81(1.83, 4.32)<0.0001
Moderate-Severe20.3(4.43, 28.59)<0.000113.42(8.90, 20.23)<0.0001
Medical History
SmokingCurrent Smoker1.77(1.34, 2.32)<0.00011.67(1.18, 2.37)0.004
Overall HealthExcellent1.00Reference1.00Reference
Very Good1.01(0.53, 1.93)0.9670.87(0.43, 1.74)0.692
Good2.15(1.21, 3.83)0.0091.35(0.72, 2.56)0.351
Fair8.85(5.00, 15.64)<0.00014.09(2.11, 7.91)<0.0001
Poor16.38(8.71, 30.81)<0.00013.00(1.38, 6.55)0.006
HypertensionYes2.86(2.21, 3.69)<0.0001
DiabetesYes3.10(2.26, 4.26)<0.0001
Heart FailureYes3.75(2.34, 6.00)<0.00011.30(0.71, 2.39)0.388
AnginaYes2.91(1.72, 4.92)0.00011.25(0.67, 2.36)0.475
Heart AttackYes3.87(2.58, 5.82)<0.00011.77(1.07, 2.94)0.027
ArthritisYes5.59(4.29, 7.29)<0.00013.66(2.57, 5.22)<0.0001
Respiratory DiseaseYes5.01(3.59, 6.98)<0.00012.23(1.52, 3.28)<0.0001
Thyroid DiseaseYes2.13(1.46, 3.11)0.00011.59(1.04, 2.44)0.033
AsthmaYes3.75(2.68, 5.25)<0.00012.13(1.41, 3.20)0.0003
DepressionPHQ Score1.19(1.16, 1.23)<0.0001
PHQ Score—Sleep1.21(1.18, 1.25)<0.0001
DiureticsYes2.52(1.84, 3.45)<0.00011.08(0.69, 1.70)0.734
Long-acting beta agonistsYes4.47(0.84, 23.70)0.0791.84(0.24, 13.94)0.055
Objective Health Variables
Body Mass Index1.04(1.03, 1.06)<0.0001
CalciumLog0.27(0.01, 5.72)0.40431.67(0.06, 47.37)0.761
FolateLog0.64(0.52, 0.78)<0.00010.94(0.81, 1.16)0.732
C-Reactive ProteinLog1.34(1.21, 1.49)<0.00011.14(0.99, 1.31)0.074
HbA1c%1.41(1.28, 1.55)<0.00011.09(0.96, 1.25)0.186
GlucoseLog3.58(2.05, 6.24)<0.00011.56(0.70, 3.51)0.280
CadmiumLog1.40(1.12, 1.76)0.0031.08(0.83, 1.41)0.566
White Blood Cell Count1.10(1.04, 1.15)0.00041.04(0.99, 1.10)0.110
Red Blood Cell Count0.54(0.43, 0.70)<0.00010.78(0.57, 1.08)0.137

* using variables with p<0.05 in 2005–2006.

** fully adjusted: age, sex, education, BMI, employment, hypertension, diabetes, depression.

Fig 1

Prevalence of nocturnal leg cramps by age, for 2005–2006 and 2007–2008.

(A) 2005–2006. (B) 2007–2008.

Prevalence of nocturnal leg cramps by age, for 2005–2006 and 2007–2008.

(A) 2005–2006. (B) 2007–2008. * using variables with p<0.05 in 2005–2006. ** fully adjusted: age, sex, education, BMI, employment, hypertension, diabetes, depression. NLC were frequently associated with other sleep symptoms. Results are depicted in Table 3 for the unadjusted and fully-adjusted models examining moderate-severe symptoms, S1 Table for analyses across models for mild symptoms, and S2 Table for other models examining moderate-severe symptoms (note that mild and moderate-severe conditions were both included in the multinomial analyses though they are separated in tables for clarity). In all models, moderate-severe NLC were associated with all sleep variables. The relationship to sleep duration was such that every hour of sleep duration was associated with a reduction in the likelihood of moderate-severe NLC by 19%. Further, symptoms of sleep apnea and insomnia were all associated with NLC. The sleep symptom for which the associations were strongest were leg jerks at night. Results from analyses examining relationships with medical history variables are also reported in Table 3 and S1 and S2 Tables. In the first three models, NLC were associated with poorer overall health, smoking, hypertension, diabetes, heart failure, angina, heart attack, arthritis, respiratory disease, thyroid disease, asthma, and depression. In the final model, no significant associations were seen for heart failure or angina; the rest were attenuated but still significant. Regarding physiologic health markers, results are also reported in Table 3 and S1 and S2 Tables. Moderate-severe NLC were associated with higher BMI, CRP, HBA1C%, glucose, cadmium, and white blood cell count, as well as decreased folate but not to calcium.

2005–2008 dataset: Stepwise regression

All variables that remained significant after adjusting for age and sex in both models were included in the stepwise model (Table 4).
Table 4

Stepwise logistic regression results of associations between nocturnal leg cramps and all significant factors (combined 2005–2008).

Model ChangeMild Nocturnal Leg CrampsModerate-Severe Nocturnal Leg Cramps
VariablePOR95% CIpOR95% CIp
Leg JerksMild<0.00013.156(2.199, 4.531)<0.00013.176(1.641, 6.147)0.001
Moderate-Severe2.769(1.567, 4.891)<0.000115.906(6.887, 36.738)<0.0001
Overall HealthVery Good<0.00010.748(0.550, 1.017)0.0640.622(0.277, 1.395)0.249
Good0.77(0.597, 0.993)0.0440.916(0.532, 1.578)0.752
Fair0.951(0.758, 1.193)0.6630.525(0.306, 0.899)0.019
Poor2.082(1.525, 2.842)<0.00013.98(2.351, 6.737)<0.0001
ArthritisYes<0.00011.667(1.183, 2.348)0.0033.469(1.897, 6.343)<0.0001
Difficulty Falling AsleepMild<0.00011.387(0.992, 1.939)0.0562.786(1.428, 5.435)0.003
Moderate-Severe1.9(1.185, 3.048)0.0082.611(1.179, 5.784)0.018
AgeYears0.00031.022(1.012, 1.032)<0.00011.03(1.010, 1.049)0.002
Non-Restorative SleepMild0.00221.096(0.763, 1.575)0.622.052(1.054, 3.996)0.034
Moderate-Severe1.806(1.184, 2.753)0.0063.846(1.826, 8.100)<0.0001
Red Blood Cell Count 0.00691.16(0.859, 1.566)0.3340.422(0.235, 0.756)0.004
EducationSome College0.01631.653(1.063, 2.568)0.0262.671(1.249, 5.711)0.011
High School1.645(1.09, 2.482)0.0181.194(0.513, 2.781)0.68
Less Than High School1.436(0.957, 2.155)0.0811.132(0.449, 2.854)0.793
AnginaYes0.02140.32(0.123, 0.833)0.020.229(0.066, 0.801)0.021
Difficulty Maintaining SleepMild0.0211.463(1.029, 2.080)0.0341.082(0.578, 2.023)0.806
Moderate-Severe0.882(0.544, 1.428)0.6091.462(0.718, 2.979)0.295

Of note, categorical variables were dummy-coded, such that each categorical variable produced k-1 dummy variables, where k is the number of categories to reduce collinearity.

Of note, categorical variables were dummy-coded, such that each categorical variable produced k-1 dummy variables, where k is the number of categories to reduce collinearity. In order of partial R2, unique contributors to the variance of nocturnal leg cramps were: leg jerks (positive relationship), overall health (positive relationship for poor health), arthritis (positive relationship), difficulty falling asleep (positive relationship), age (positive relationship), non-restorative sleep (positive relationship), red blood cell count (negative relationship), education (positive relationship for only those with some college), angina (negative relationship with moderate-severe leg cramps), and difficulty maintaining sleep (positive relationship only for mild NLC). Because the relationship with leg jerks was so strong, the stepwise analysis was run excluding the leg jerks variable (See S3 Table) to determine which variables would be related to leg cramps if the variance accounted for by leg jerks was excluded. In this case, the order of variables changed slightly, and asthma and HbA1c% were added to the list (both positive relationships). Since overall health is a non-specific variable, a third stepwise regression analysis was performed excluding both leg jerks and overall health. Results of this model, displayed in S3 Table, shows that depression was added to the list.

Discussion

This is the first large-scale, population-level epidemiologic investigation of NLC. We found that 30% of adults report having NLC at least 5 times per month, with 6% reporting them at least 15 times per month. These prevalence rates were consistent between the two waves two years apart. As analyses were cross-sectional, causal relationships between NLC and specific medical conditions or biomarkers cannot be established. However, important predictors of frequent NLC were established from these cohorts and were generally consistent between the two waves. It is notable that in the models and the stepwise analyses, the associations with health outcomes were consistently stronger as the frequency of NLC increased, increasing our confidence in the validity of these associations. For example, the relationships with poor overall health and multiple medical illnesses and depression increased in strength as the frequency of NLC increased. Similarly, relationships with NLC were generally stronger for predicting moderate-severe symptoms versus mild symptoms of sleep disturbance. Consistent with previous studies in small, mostly older populations, advancing age was associated with more frequent NLC[4, 7, 13]. It is unclear which features of aging independently predispose to NLC; however, the association could also be a proxy for medical illnesses which were not assessed in this NHANES wave, such as peripheral arterial disease and/or peripheral neuropathy. Although NLC were more common in women than men, which is consistent with some[13], but not all[4], previous studies, sex was not an independent risk factor in the stepwise regression after factoring in other variables (leg jerks, overall health, arthritis, etc.). No race/ethnicity differences in reports of NLC were observed, though Hispanic/Latino ethnicity was protective in the 2007–2008 cohort after full adjustment for health and demographic variables. NLC were highly associated (in unadjusted models) with multiple prevalent medical disorders, including depression, and cardiovascular, arthritis, and respiratory diseases. However, worse overall perceived health, more than any particular medical condition, was the strongest predictor of NLC of all health variables. Among specific medical conditions, and persisting after controlling for overall health, arthritis had a positive association with NLC. This association had been suggested by a previous small primary care study[5]. It is unclear whether it is the inflammatory state or damage to peripheral nerves that is responsible for this association with arthritis. The association of cardiovascular symptoms and diseases with frequent NLC is complex. In unadjusted models, hypertension, heart failure and angina all were associated with more frequent NLC. Of note, in the stepwise regression, angina was a protective factor (those with angina were more likely to experience leg cramps in the logistic regression analyses but the direction was reversed in the stepwise regression). It is possible that those individuals with persistent angina use medications (e.g., nitrates) which are protective for NLC or avoid medications (e.g., long-acting beta agonists) which are thought to aggravate NLC[9]. The strongest association of a laboratory value to frequent NLC was with red blood cell count. In the stepwise regression for every increase of one million cells per microliter, the likelihood of moderate-severe NLC decreased by 57%. Interestingly, serum levels of iron and vitamins B12, B6, and E were not associated with NLC in adjusted models, each of which has been investigated as a treatment for frequent NLC[8]. An elevated HbA1c was also associated with frequent NLC, as were diabetes and fasting glucose (but not insulin), and the former variable was present after overall health was removed from the stepwise regression. Poorly controlled diabetes may be responsible for the association with NLC due to microvascular or neuropathic changes[14]. The absence of information on peripheral vascular disease and neuropathy in these NHANES cohorts makes interpretation of this association more difficult. The most powerful single association with NLC is to self-reported "nocturnal leg jerks". The intent of this question in the NHANES surveys was to assess the prevalence of periodic limb movements of sleep (PLMS), a common sleep-related feature[15]. These movements involve rhythmic dorsiflexion of the ankle and at times, flexion at the knee, and last 0.5–10 seconds. They are more common with age and in those taking serotonergic reuptake inhibitors, and less common in African-Americans[16]. It is possible that such leg movements may provoke leg cramps in vulnerable individuals. Polysomnographic investigation into those with NLC may assist with this issue. Another possible explanation for this association is that NHANES respondents believed the question about "leg jerks" referred to NLC thus creating a spurious association between the two. To assess this association further, a Spearman correlation was computed. In this analysis, Rho = 0.35, suggesting that these constructs modestly overlap. For example, among those with moderate-severe leg jerks, 40% also experienced moderate-severe NLC as well, whereas 32% experienced no NLC at all. Multiple sleep variables were associated with frequent NLC in partially controlled models. In the stepwise regression both difficulty falling asleep and non-restorative sleep were associated with frequent NLC, whereas difficulty maintaining sleep only emerged when leg jerks were removed from the model. This is surprising as NLC are usually associated with awakenings from sleep[17]. Although sleep medications were associated with frequent NLC, they were not a predictor in the stepwise regression suggesting that sleep disturbance, rather than sleep medications, is the relevant association. Similarly, the absence of indicators of sleep apnea, e.g., BMI, snoring, or snorting/gasping as predictors in the stepwise regression suggests that this sleep disorder is not an important independent contributor to NLC. There are a number of limitations of this investigation. NLC were only assessed with one question, in a overall study not primarily addressing this symptom, limiting the reliability of the case ascertainment. Peripheral neuropathy and peripheral vascular disease were not assessed in these NHANES waves and thus the associations of these common neurological and vascular disorders with NLC could not be assessed. Activity level, another potential contributor to NLC, could also not be assessed due to inconsistent methods of evaluation in the two NHANES waves. Finally, restless legs syndrome (RLS) diagnosis was not assessed in either of these NHANES waves, and it is possible that misclassification of RLS as NLC may account for some of the medical and sleep comorbidities we observed with NLC, which are also present with RLS [18, 19]. The results of this first cross-sectional study based on a representative population demonstrate that NLC occur >15x/month in 6% of the population, more commonly with advancing age and in women, and are associated with poorer self-reported health, multiple sleep disturbance symptoms, abnormal laboratory tests, and multiple chronic medical conditions including depression. The extent to which such NLC are a marker or a cause of medical and psychiatric disability is unclear, and future research should address both their consequences for health as well as their underlying pathophysiology.

Associations with mild leg cramps in 2007–2008*.

* using variables with p<0.05 in 2005–2006, ** ** adjusted for age, sex, education, BMI, employment, hypertension, diabetes, depression. (DOCX) Click here for additional data file.

Associations with moderate-severe nocturnal leg cramps in 2007–2008, models adjusted for (1) age and sex and (2) age, sex, education, and body mass index*.

* using variables with p<0.05 in 2005–2006. (DOCX) Click here for additional data file.

Stepwise logistic regression results of associations between nocturnal leg cramps and all significant factors, excluding leg jerks and/or overall health (combined 2005–2008).

(DOCX) Click here for additional data file.
  16 in total

Review 1.  Past and current understanding of the pathophysiology of muscle cramps: why treatment of varicose veins does not relieve leg cramps.

Authors:  P H Jansen; R G Lecluse; A L Verbeek
Journal:  J Eur Acad Dermatol Venereol       Date:  1999-05       Impact factor: 6.166

2.  The incidence of muscle cramp.

Authors:  P H Jansen; E M Joosten; J Van Dijck; A L Verbeek; F W Durian
Journal:  J Neurol Neurosurg Psychiatry       Date:  1991-12       Impact factor: 10.154

3.  Prevalence of muscle cramps in patients with diabetes.

Authors:  Hans Katzberg; Seint Kokokyi; Elise Halpern; Eric Lovblom; Carolina Barnett; Drew Hume; Vera Bril; Bruce Perkins
Journal:  Diabetes Care       Date:  2014       Impact factor: 19.112

Review 4.  Restless legs syndrome and cardiovascular disease: a research roadmap.

Authors:  Daniel J Gottlieb; Virend K Somers; Naresh M Punjabi; John W Winkelman
Journal:  Sleep Med       Date:  2016-10-27       Impact factor: 3.492

5.  The PHQ-9: validity of a brief depression severity measure.

Authors:  K Kroenke; R L Spitzer; J B Williams
Journal:  J Gen Intern Med       Date:  2001-09       Impact factor: 5.128

6.  Factors associated with night-time calf muscle cramps: a case-control study.

Authors:  Fiona Hawke; Vivienne Chuter; Joshua Burns
Journal:  Muscle Nerve       Date:  2012-11-21       Impact factor: 3.217

7.  Nocturnal leg cramps and prescription use that precedes them: a sequence symmetry analysis.

Authors:  Scott R Garrison; Colin R Dormuth; Richard L Morrow; Greg A Carney; Karim M Khan
Journal:  Arch Intern Med       Date:  2011-12-12

Review 8.  Periodic leg movements in sleep and periodic limb movement disorder: prevalence, clinical significance and treatment.

Authors:  Magdolna Hornyak; Bernd Feige; Dieter Riemann; Ulrich Voderholzer
Journal:  Sleep Med Rev       Date:  2006-06       Impact factor: 11.609

9.  Leg symptoms in outpatient veterans.

Authors:  S K Oboler; A V Prochazka; T J Meyer
Journal:  West J Med       Date:  1991-09

Review 10.  A review of nocturnal leg cramps in older people.

Authors:  Louise Rabbitt; Eamon C Mulkerrin; Shaun T O'Keeffe
Journal:  Age Ageing       Date:  2016-08-11       Impact factor: 10.668

View more
  3 in total

1.  Mac-2-binding protein glycosylation isomer is useful to predict muscle cramps in patients with chronic liver disease.

Authors:  Takao Miwa; Tatsunori Hanai; Yuko Sakai; Takahiro Kochi; Naoki Katsumura; Masahito Shimizu
Journal:  Medicine (Baltimore)       Date:  2022-10-14       Impact factor: 1.817

Review 2.  Environmental exposures and sleep outcomes: A review of evidence, potential mechanisms, and implications.

Authors:  Jianghong Liu; Lea Ghastine; Phoebe Um; Elizabeth Rovit; Tina Wu
Journal:  Environ Res       Date:  2020-10-29       Impact factor: 6.498

3.  The Endocannabinoid System May Modulate Sleep Disorders in Aging.

Authors:  Eric Murillo-Rodríguez; Henning Budde; André Barciela Veras; Nuno Barbosa Rocha; Diogo Telles-Correia; Diogo Monteiro; Luis Cid; Tetsuya Yamamoto; Sérgio Machado; Pablo Torterolo
Journal:  Curr Neuropharmacol       Date:  2020       Impact factor: 7.363

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.